胶质瘤
药物输送
医学
放射治疗
脑瘤
癌症研究
胶质母细胞瘤
纳米技术
材料科学
病理
内科学
作者
Cedric Kier Lansangan,Menka Khoobchandani,Ruchit Jain,Serge Rudensky,Christopher C. Perry,Rameshwar Patil
出处
期刊:Materials
[Multidisciplinary Digital Publishing Institute]
日期:2024-03-01
卷期号:17 (5): 1153-1153
被引量:5
摘要
Glioblastoma multiforme (GBM) is a glioma and the most aggressive type of brain tumor with a dismal average survival time, despite the standard of care. One promising alternative therapy is boron neutron capture therapy (BNCT), which is a noninvasive therapy for treating locally invasive malignant tumors, such as glioma. BNCT involves boron-10 isotope capturing neutrons to form boron-11, which then releases radiation directly into tumor cells with minimal damage to healthy tissues. This therapy lacks clinically approved targeted blood–brain-barrier-permeating delivery vehicles for the central nervous system (CNS) entry of therapeutic boron-10. Gold nanoparticles (GNPs) are selective and effective drug-delivery vehicles because of their desirable properties, facile synthesis, and biocompatibility. This review discusses biomedical/therapeutic applications of GNPs as a drug delivery vehicle, with an emphasis on their potential for carrying therapeutic drugs, imaging agents, and GBM-targeting antibodies/peptides for treating glioma. The constraints of GNP therapeutic efficacy and biosafety are discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI